Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury
Grigorios Christidis(Saarland University), Senem Ceren Karataylı(Saarland University)
Cited by 14
Related Papers
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV‐1 study
|Hepatology|2017|150
Fibroblast growth factor 21 response in a preclinical alcohol model of acute-on-chronic liver injury
|Zeitschrift für Gastroenterologie|2020|0